Company Filing History:
Years Active: 2024
Title: Patricia Crisanti-Lassiaz: Innovator in Retinal Treatment
Introduction
Patricia Crisanti-Lassiaz is a notable inventor based in Paris, France. She has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal conditions. Her innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
Patricia holds a patent for "Methods and pharmaceutical compositions for the treatment of retinal capillary non-perfusion." This invention focuses on methods and pharmaceutical compositions aimed at treating retinal capillary non-perfusion. Specifically, it involves administering a therapeutically effective amount of a ROCK inhibitor to subjects in need of treatment.
Career Highlights
Throughout her career, Patricia has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Paris Descartes. Her experience in these organizations has allowed her to advance her research and contribute to significant medical advancements.
Collaborations
Patricia has collaborated with Francine Behar-Cohen, a fellow researcher in the field. Their partnership has fostered innovative approaches to retinal treatment and has enhanced the impact of their work.
Conclusion
Patricia Crisanti-Lassiaz is a pioneering inventor whose work in retinal treatment has the potential to improve the lives of many individuals suffering from retinal capillary non-perfusion. Her contributions to medical science are invaluable and continue to inspire future innovations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.